delivered the opinion of the Court.
This case raises some complex questions about the Securities and Exchange Commission’s power to regulate
The Commission was denied temporary relief, and shortly thereafter Producers’ shareholders and the Arizona Director of Insurance approved the merger. The
Insofar as it is relevant to this ease, § 2 (b) of the McCarran-Ferguson Act provides that “[n]o Act of Congress shall be construed to invalidate, impair, or supersede any law enacted by any State for the purpose of regulating the business of insurance . . . unless such Act specifically relates to the business of insurance . . ..” Respondents contend that this Act bars the present suit since the Arizona Director of Insurance found that the merger was not “[Unequitable to the stockholders of any domestic insurer” and not otherwise “contrary to law,” as he was required to do under the state insurance laws. Ariz. Rev. Stat. Ann. § 20-731 (Supp. 1969). If the Securities Exchange Act were applied, respondents argue, these laws would be “superseded.” The SEC sees no conflict between state and federal law; it contends that the applicable Arizona statutes did not give the State Insurance Director the power to determine whether respondents had made full disclosure in connection with the solicitation of proxies. 2 Although respondents disagree, we do not find it necessary to inquire into this state-law dispute. The first question posed by this case is whether the relevant Arizona statute is a “law enacted ... for the purpose of regulating the business of insurance” within the meaning of the McCarran-Ferguson Act. Even accepting respondents’ view of Arizona law, we do not believe that a state statute aimed at protecting the interests of those who own stock in insurance companies comes within the sweep of the McCarran-Ferguson Act. Such a statute is not a state attempt to regulate “the business of insurance,” as that phrase was used in the Act.
The question here is whether state laws aimed at protecting the interests of those who own securities in insurance companies are the type of laws referred to in the 1945 enactment. The legislative history of the McCarran-Ferguson Act offers no real assistance. Congress was mainly concerned with • the relationship be
Given this history, the language of the statute takes on a different coloration. The statute did not purport to make the States supreme in regulating all the activities of insurance
companies;
its language refers not to the persons or companies who are subject to state regulation, but to laws “regulating the
business
of insurance.” Insurance companies may do many things which are subject to paramount federal regulation; only when they
In this case, Arizona is concerning itself with a markedly different set of problems. It is attempting to regulate not the “insurance” relationship, but the relationship between a stockholder and the company in which he owns stock. This is not insurance regulation, but securities regulation. It is true that the state statute applies only to insurance companies. But mere matters of form need not detain us. The crucial point is that here the State has focused its attention on stockholder protection; it is not attempting to secure the interests of those purchasing insurance policies. Such regulation is not within the scope of the McCarran-Ferguson Act.
II.
The fact remains, however, that the State of Arizona has approved a merger between two insurance companies
The Commission alleged that approval of the merger was obtained through the use of various fraudulent misrepresentations. It did not ask the trial court to pass directly upon a merger which the State Director of Insurance had approved. No question of the legality or illegality of the merger, standing alone, was raised. The gravamen of the complaint was the misrepresentation, not the merger. The merger became relevant only insofar as it was necessary to attack it in order to undo the harm caused by the alleged deception. Presumably, full
It is clear that any “impairment” in this case is a most indirect one. The Federal Government is attempting to protect security holders from fraudulent misrepresentations; Arizona, insofar as its activities are protected by the McCarran-Ferguson Act from the normal operations of the Supremacy Clause, is attempting to protect the interests of the policyholders. Arizona has not commanded something which the Federal Government seeks to prohibit. It has permitted respondents to consummate the merger; it did not order them to do so. In this context, all the Securities and Exchange Commission is asking is that insurance companies speak the truth when talking to their shareholders. The paramount federal interest in protecting shareholders is in this situation perfectly compatible with the paramount state interest in protecting policyholders. And the remedy the Commission seeks does not affect a matter predominantly of concern to policyholders alone; the merger is at least as important to those owning the companies’ stock as it is to those holding their policies. In these circumstances, we simply cannot see the conflict. Different questions would, of course, arise if the Federal Government were attempting to regulate in the sphere reserved primarily to the States by the McCarran-Ferguson Act. But that is not this case. In these circumstances, there is no reason to emasculate the securities laws by forbidding remedies which might prove to be essential. Cf.
J. I. Case Co.
v.
Borak,
III.
Respondents argue that there are alternative grounds on which the lower courts’ action in granting judgment on the pleadings can be sustained. They contend that the complaint fails to allege a “purchase or sale” of securities within the meaning of § 10 (b) and the Commission’s Rule 10b-5, and that in any case Rule 10b-5 does not apply to misrepresentations in connection with the solicitation of proxies.
6
Since this case is here in the context of an appeal from the pretrial dismissal of a complaint, a simple remand would leave the lower
Although § 10 (b) and Rule 10b-5 may well be the most litigated provisions in the federal securities laws, this is the first time this Court has found it necessary to interpret them. We enter this virgin territory cautiously. The questions presented are narrow ones. They arise in an area where glib generalizations and unthinking abstractions are major occupational hazards. Accordingly, in deciding this particular case, remembering what is not involved is as important as determining what is. With this in mind, we turn to respondents’ particular contentions.
Respondents argue that the complaint fails to allege any misstatements “in connection with the purchase or sale of any security,” as is required by both the statute and the rule. They rely upon the so-called “no-sale doctrine” presently set forth in the Commission’s Rule 133 under the Securities Act of 1933, 17 CFR § 230.133 (1968).
7
That rule, promulgated under the Commission’s authority to define “accounting, technical, and trade terms” used in the 1933 Act, § 19 (a), 48 Stat. 85, as amended, 15 U. S. C. § 77s, sets forth various situations involving statutory mergers and other types of corporate reorganizations, and declares that no “sale” or “offer” shall be deemed to be involved. But whatever may be the validity or effect of this rule — and we intimate
Section 10 (b) and Rule 10b-5 together constitute one of the several broad antifraud provisions contained in the securities laws. In the context of this case, the Commission seeks to apply them to prevent the shareholders of Producers from being defrauded as a result of misstatements made by respondents. For the statute and the rule to apply, the allegedly proscribed conduct must have been “in connection with the purchase or sale of any security.” The relevant definitional sections of the 1934 Act are for the most part unhelpful; they only declare generally that the terms “purchase” and “sale” shall include contracts to purchase or sell. §§3(a)(13), (14), 48 Stat. 884, 15
According to the amended complaint, Producers’ shareholders were misled in various material respects prior to their approval of a merger. The deception furthered a scheme which resulted in their losing their status as shareholders in Producers and becoming shareholders in a new company. Moreover, by voting in favor of the merger, each approving shareholder individually lost any right under Arizona law to obtain an appraisal of his stock and payment for it in cash. Ariz. Rev. Stat. Ann. § 10-347 (1956). Whatever the terms “purchase” and “sale” may mean in other contexts, here an alleged deception has affected individual shareholders’ decisions in a way not at all unlike that involved in a typical cash sale or share exchange. The broad anti-fraud purposes of the statute and the rule would clearly be furthered by their application to this type of situation. Therefore we conclude that Producers’ shareholders “purchased” shares in the new company by exchanging them for their old stock.
9
As the Court of Appeals for the Seventh Circuit has said, “This view does no violence to the statutory language, and is the
Respondents’ alternative argument that Rule 10b-5 does not cover misrepresentations which occur in connection with proxy solicitations can be dismissed rather quickly. Section 14 of the 1934 Act, 48 Stat. 895, 15 U. S. C. § 78n, and the rules adopted pursuant to that section, 17 CFR §§ 240.14a-l to 240.14a-103 (1968), set up a complex regulatory scheme covering proxy solicitations. At the time of the conduct charged in the complaint, these provisions did not apply to respondents; the 1964 amendments to the Securities Exchange Act would have made them applicable later if certain conditions relating to state regulation had not been met. 78 Stat. 567, 15 U. S. C. §
781
(g)(2)(G). But the existence or nonexistence of regulation under § 14 would not affect the scope of § 10 (b) and Rule 10b-5. The two sections of the Act apply to different sets of situations. Section 10 (b) applies to all proscribed conduct in connection with a purchase or sale of any security; § 14 applies to all proxy solicitations, whether or not in connection with a purchase or sale. The fact that there may well be some overlap is neither unusual nor unfortunate. Nor does it help respondents that insurance companies may often be exempt from federal proxy regulation under the 1964 amendments. The securities laws’ exemptions for insurance companies and insurance activities are carefully limited. None is applicable to the Rule 10b-5 situation with which we are confronted, and we do not have the power to create one. Congress
Since the McCarran-Ferguson Act does not prohibit the relief sought, and since neither of the alternative grounds for dismissal which have been raised here is meritorious, we reverse the judgment of the Court of Appeals and remand the case to the District Court for further proceedings consistent with this opinion.
It is so ordered.
believing that the United States Court of Appeals for the Ninth Circuit correctly analyzed the issues in this case and that its judgment is right, dissents from this Court’s reversal of the judgment.
I concur entirely in Parts I and II of the Court’s opinion construing the McCarran-Ferguson Act. But I am at a loss to understand why the Court finds it necessary to go further and construe Rule 10b-5 promulgated under § 10 (b) of the Securities Exchange Act of 1934. The Court of Appeals did not reach this question since it believed that the McCarran-Ferguson Act entirely exempted the transaction involved here from the commands of the federal securities laws. The Government’s petition for certiorari is similarly limited. The only issue it raises is “[wjhether the McCarran-Ferguson Act . . . precludes the application of the anti-fraud provisions of
Despite the fact that we have not heard the views of the Securities and Exchange Commission, the Court chooses this case as a vehicle to construe for the first time one of the most important and elusive provisions of the securities laws. Moreover, the decision has far-reaching radiations, despite the fact that the precise issue presented is a narrow one. Courts and commentators have long debated whether Rule 10b-5 should be read as a sweeping prohibition against fraud in the securities industry when this results in rendering nullities of the other antifraud provisions of more limited scope which can be found in the statute books. See,
e. g.,
§§ 11(a), 12 (2), and 13 of the Securities Act of 1933; § 18 of the Securities and Exchange Act of 1934. The late Judge Jerome Frank,
1
Professor Louis Loss,
2
and Milton Cohen,
3
— to mention only three of those particularly eminent in this field — have warned that Rule 10b-5 should not be construed to supersede the special statutory schemes which Congress has devised to assure fair dealing in various aspects of the securities business. But see A. Bromberg, Securities Law § 2.5 (1967);
Ellis
v.
Carter,
In addition, the Court has chosen to adopt a very loose construction of the requirement, first enunciated by Judge Augustus Hand in
Birnbaum
v.
Newport Steel Corp.,
Notes
“No Act of Congress shall be construed to invalidate, impair, or supersede any law enacted by any State for the purpose of regulating the business of insurance, or which imposes a fee or tax upon such business, unless such Act specifically relates to the business of insurance: Provided, That after June 30, 1948, the Act of July 2, 1890, as amended, known as the Sherman Act, and the Act of October 15, 1914, as amended, known as the Clayton Act, and the Act of September 26, 1914, known as the Federal Trade Commission Act, as amended, shall be applicable to the business of insurance to the extent that such business is not regulated by State law.”
In 1966 Arizona law was amended to give him this power. See Ariz. Rev. Stat. Ann. §20-143 (Supp. 1969). This statute was passed in response to the 1964 amendments to the Securities Exchange Act. Pub. L. 88-467, 78 Stat. 565.
E. g., Securities Act of 1933, § 3 (a) (8), 48 Stat. 76, 15 U. S. C. § 77c (a) (8); Securities Exchange Act of 1934, § 12 (g) (2) (G), added by Pub. L. 88-467, 78 Stat. 567 (1964), 15 U. S. C. § 781 (g) (2)(G).
The Commision lists a large number of examples of its activities in its brief. Brief for Petitioner 16-17.
Although the District Court held that some of the relief requested was beyond that properly allowable under § 21 (e) of the 1934 Act, 48 Stat. 900, as amended, 15 U. S. C. § 78u (e), no such question has been argued by either party here. Accordingly, we express no opinion about the proper construction of that section. See Note, Ancillary Relief in SEC Injunction Suits for Violation of Rule 10b-5, 79 Harv. L. Rev. 656 (1966).
Section 10 (b) of the Securities Exchange Act of 1934, 48 Stat. 891, 15 U. S. C. §78j (b), provides:
“It shall be unlawful for any person, directly or indirectly, by the use of any means or instrumentality of interstate commerce or of the mails, or of any facility of any national securities exchange—
“(b) To use or employ, in connection with the purchase or sale of any security registered on a national securities exchange or any security not so registered, any manipulative or deceptive device or contrivance in contravention of such rules and regulations as the Commission may prescribe as necessary or appropriate in the public interest or for the protection of investors.”
Rule 10b-5, 17 CFR § 240.10b-5 (1968), provides:
“It shall be unlawful for any person, directly or indirectly, by the use of any means or instrumentality of interstate commerce, or of the mails or of any facility of any national securities exchange,
“(a) To employ any device, scheme, or artifice to defraud,
“(b) To make any untrue statement of a material fact or to omit to state a material fact necessary in order to make the statements made, in the light of the circumstances under which they were made, not misleading, or
“(c) To engage in any act, practice, or course of business which operates or would operate as a fraud or deceit upon any person, in connection with the purchase or sale of any security.”
For the history of this doctrine, see 1 L. Loss, Securities Regulation 518-542 (1961).
These sections do indicate the breadth of the statutory terms by using the definitional word “include” and by including within the definitions contracts “to buy, purchase, or otherwise acquire” and “to sell or otherwise dispose of” securities.
This case presents none of the complications which may arise in determining who, if anyone, may bring private actions under § 10 (b) and Rule 10b-5. Cf.
J. I. Case Co.
v.
Borak,
Fischman
v.
Raytheon Manufacturing Co.,
3 Securities Regulation 1787-1791 (1961).
“Truth in Securities” Revisited, 79 Harv. L. Rev. 1340, 1370 n. 89 (1966).
Both O’Neill and Birnbaum were of course private actions, and I do not mean to suggest that my Brother Marshall is flatly inconsistent in now ruling that the “purchase” and “sale” requirement has been met in this case involving the SEC’s request for an injunction. Nevertheless, both private and public actions arise under the same Rule, and the legal problems involved in the two situations, while not identical, are closely related.
